BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 22594862)

  • 1. Polycystic ovary syndrome: a common but often unrecognized condition.
    Shannon M; Wang Y
    J Midwifery Womens Health; 2012; 57(3):221-30. PubMed ID: 22594862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnosis of polycystic ovary syndrome in adolescents.
    Carmina E; Oberfield SE; Lobo RA
    Am J Obstet Gynecol; 2010 Sep; 203(3):201.e1-5. PubMed ID: 20435290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycystic ovary syndrome.
    King J
    J Midwifery Womens Health; 2006; 51(6):415-22. PubMed ID: 17081931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of electro-acupuncture and physical exercise on hyperandrogenism and oligo/amenorrhea in women with polycystic ovary syndrome: a randomized controlled trial.
    Jedel E; Labrie F; Odén A; Holm G; Nilsson L; Janson PO; Lind AK; Ohlsson C; Stener-Victorin E
    Am J Physiol Endocrinol Metab; 2011 Jan; 300(1):E37-45. PubMed ID: 20943753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical expression of polycystic ovary syndrome in adolescent girls.
    Sultan C; Paris F
    Fertil Steril; 2006 Jul; 86 Suppl 1():S6. PubMed ID: 16798287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka.
    Kumarapeli V; Seneviratne Rde A; Wijeyaratne CN; Yapa RM; Dodampahala SH
    Am J Epidemiol; 2008 Aug; 168(3):321-8. PubMed ID: 18550559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of polycystic ovarian syndrome in Indian adolescents.
    Nidhi R; Padmalatha V; Nagarathna R; Amritanshu R
    J Pediatr Adolesc Gynecol; 2011 Aug; 24(4):223-7. PubMed ID: 21600812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary amenorrhea as a manifestation of polycystic ovarian syndrome in adolescents: a unique subgroup?
    Rachmiel M; Kives S; Atenafu E; Hamilton J
    Arch Pediatr Adolesc Med; 2008 Jun; 162(6):521-5. PubMed ID: 18524741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proposed criteria for the identification of polycystic ovary syndrome following menopause: An ancillary study of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
    Gabrielli L; de Almeida Mda C; Aquino EM
    Maturitas; 2015 Jul; 81(3):398-405. PubMed ID: 26004079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria.
    March WA; Moore VM; Willson KJ; Phillips DI; Norman RJ; Davies MJ
    Hum Reprod; 2010 Feb; 25(2):544-51. PubMed ID: 19910321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
    Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperandrogenemia is implicated in both the metabolic and reproductive morbidities of polycystic ovary syndrome.
    Sung YA; Oh JY; Chung H; Lee H
    Fertil Steril; 2014 Mar; 101(3):840-5. PubMed ID: 24424368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis and treatment of polycystic ovary syndrome].
    Langmár Z
    Orv Hetil; 2010 Apr; 151(14):584-6. PubMed ID: 20332077
    [No Abstract]   [Full Text] [Related]  

  • 14. High Prevalence of Polycystic Ovary Syndrome in Type 1 Diabetes Mellitus Adolescents: Is There a Difference Depending on the NIH and Rotterdam Criteria?
    Busiah K; Colmenares A; Bidet M; Tubiana-Rufi N; Levy-Marchal C; Delcroix C; Jacquin P; Martin D; Benadjaoud L; Jacqz-Aigrain E; Laborde K; Robert JJ; Samara-Boustani D; Polak M
    Horm Res Paediatr; 2017; 87(5):333-341. PubMed ID: 28437788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary forms of polycystic ovary syndrome.
    Kaltsas GA; Isidori AM; Besser GM; Grossman AB
    Trends Endocrinol Metab; 2004 Jul; 15(5):204-10. PubMed ID: 15223049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis, phenotype, and prevalence of polycystic ovary syndrome.
    Carmina E; Azziz R
    Fertil Steril; 2006 Jul; 86 Suppl 1():S7-8. PubMed ID: 16798288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
    Barber TM; Wass JA; McCarthy MI; Franks S
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome.
    Hart R; Hickey M; Franks S
    Best Pract Res Clin Obstet Gynaecol; 2004 Oct; 18(5):671-83. PubMed ID: 15380140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-selected women with polycystic ovary syndrome are reproductively and metabolically abnormal and undertreated.
    Legro RS; Urbanek M; Kunselman AR; Leiby BE; Dunaif A
    Fertil Steril; 2002 Jul; 78(1):51-7. PubMed ID: 12095490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimal difference in phenotype between adolescents and young adults with polycystic ovary syndrome.
    Zore T; Lizneva D; Brakta S; Walker W; Suturina L; Azziz R
    Fertil Steril; 2019 Feb; 111(2):389-396. PubMed ID: 30527835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.